Moreover, FAT10 limits the efficacy of anti-VEGF therapy for hepatocellular carcinoma by simultaneously stabilising multiple proteins, including HIF1α, β-catenin, STAT3, and TAB3 proteins [33]. The gene discussed is TAB3; the disease is hepatocellular carcinoma.